Interstitial Lung Disease

Interstitial Lung Disease (ILD), or Diffuse Parenchymal Lung Disease (DPLD), encompasses a group of lung conditions affecting the interstitial tissue surrounding the alveoli. It involves various components such as alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. ILD may develop when lung damage triggers an abnormal healing response, resulting in scarred and thickened tissue around the alveoli, making it difficult for oxygen to enter the bloodstream. Causes include exposure to hazardous chemicals, certain medications, and medical treatments, though often the exact reasons are unknown. Lung damage in ILD is typically irreversible and progressive, worsening over time. Treatment may involve medications to slow progression or, in severe cases, lung transplantation. Idiopathic Pulmonary Fibrosis is a type of ILD with no identifiable cause, often associated with characteristic radiographic and pathological findings.

  • What are the causes of interstitial lung disorder?
  • Diagnosis for Interstitial lung disorder
  • What are the treatments for interstitial lung disorder?
  • Risk factors for interstitial lung disorder
  • Complications for Interstitial lung disorder

 

    Related Conference of Interstitial Lung Disease

    November 28-29, 2024

    12th Annual Congress on Pulmonary and Critical Care

    Paris, France
    May 14-15, 2025

    4th World Summit on COPD

    Barcelona, Spain

    Interstitial Lung Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in